| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transporter activity | CACNA1S SLC9A8 SLC38A10 SLC36A1 SLCO4C1 P2RX4 SLC39A3 SLC22A16 SLC6A16 CLN3 SLC2A7 SLC35E2A NPC1L1 SLC34A2 SLC43A3 SLC35E2B SLC26A1 SLC6A14 CDH17 SLC22A31 | 5.04e-07 | 1289 | 87 | 20 | GO:0005215 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC9A8 SLC36A1 SLCO4C1 SLC6A16 SLC35E2A SLC34A2 SLC35E2B SLC26A1 SLC6A14 CDH17 | 6.44e-07 | 296 | 87 | 10 | GO:0015291 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | CACNA1S SLC9A8 SLC38A10 SLC36A1 SLCO4C1 P2RX4 SLC39A3 SLC22A16 SLC6A16 SLC2A7 SLC35E2A SLC34A2 SLC43A3 SLC35E2B SLC26A1 SLC6A14 CDH17 SLC22A31 | 2.67e-06 | 1180 | 87 | 18 | GO:0022857 |
| GeneOntologyMolecularFunction | virus receptor activity | 3.49e-05 | 85 | 87 | 5 | GO:0001618 | |
| GeneOntologyMolecularFunction | exogenous protein binding | 3.69e-05 | 86 | 87 | 5 | GO:0140272 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC9A8 SLC36A1 SLCO4C1 SLC6A16 SLC35E2A SLC34A2 SLC35E2B SLC26A1 SLC6A14 CDH17 | 4.25e-05 | 477 | 87 | 10 | GO:0022804 |
| GeneOntologyMolecularFunction | carnitine transmembrane transporter activity | 2.78e-04 | 6 | 87 | 2 | GO:0015226 | |
| GeneOntologyMolecularFunction | netrin receptor activity | 2.78e-04 | 6 | 87 | 2 | GO:0005042 | |
| GeneOntologyMolecularFunction | amine transmembrane transporter activity | 6.62e-04 | 9 | 87 | 2 | GO:0005275 | |
| GeneOntologyMolecularFunction | cysteine-type endopeptidase inhibitor activity | 8.69e-04 | 43 | 87 | 3 | GO:0004869 | |
| GeneOntologyMolecularFunction | ATP-dependent diacylglycerol kinase activity | 1.01e-03 | 11 | 87 | 2 | GO:0004143 | |
| GeneOntologyMolecularFunction | aromatic amino acid transmembrane transporter activity | 1.42e-03 | 13 | 87 | 2 | GO:0015173 | |
| GeneOntologyBiologicalProcess | regulation of cell killing | 3.72e-05 | 147 | 87 | 6 | GO:0031341 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte mediated immunity | 4.16e-05 | 150 | 87 | 6 | GO:0002708 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte mediated immunity | 5.66e-05 | 232 | 87 | 7 | GO:0002706 | |
| GeneOntologyBiologicalProcess | organic anion transport | SLC38A10 SLC36A1 SLCO4C1 P2RX4 CLN3 APBA1 SLC43A3 SLC26A1 SLC6A14 CYB5R1 | 6.17e-05 | 515 | 87 | 10 | GO:0015711 |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte mediated immunity | 9.79e-05 | 175 | 87 | 6 | GO:0002705 | |
| GeneOntologyCellularComponent | apical part of cell | SLC9A8 SLC36A1 P2RX4 SLC39A3 SLC2A7 NPC1L1 CD55 SLC34A2 DUOX2 UPK3A SLC6A14 | 3.42e-05 | 592 | 87 | 11 | GO:0045177 |
| GeneOntologyCellularComponent | apical plasma membrane | SLC9A8 SLC36A1 SLC39A3 SLC2A7 NPC1L1 CD55 SLC34A2 DUOX2 UPK3A SLC6A14 | 3.45e-05 | 487 | 87 | 10 | GO:0016324 |
| GeneOntologyCellularComponent | lysosome | SLC36A1 SERPINB13 SLCO4C1 P2RX4 SERPINB3 CLN3 HYAL3 HLA-G LAMP1 FUCA2 HSPA8 | 5.34e-04 | 811 | 87 | 11 | GO:0005764 |
| GeneOntologyCellularComponent | lytic vacuole | SLC36A1 SERPINB13 SLCO4C1 P2RX4 SERPINB3 CLN3 HYAL3 HLA-G LAMP1 FUCA2 HSPA8 | 5.34e-04 | 811 | 87 | 11 | GO:0000323 |
| Domain | MFS_dom | 2.39e-06 | 134 | 84 | 7 | IPR020846 | |
| Domain | DAG_kinase_N | 5.98e-05 | 3 | 84 | 2 | PF14513 | |
| Domain | DAG_kinase_typeI_N | 5.98e-05 | 3 | 84 | 2 | IPR029477 | |
| Domain | - | 5.98e-05 | 3 | 84 | 2 | 1.10.238.110 | |
| Domain | MFS | 1.26e-04 | 108 | 84 | 5 | PS50850 | |
| Domain | UPA | 1.98e-04 | 5 | 84 | 2 | IPR033772 | |
| Domain | Sterol-sensing | 1.98e-04 | 5 | 84 | 2 | PF12349 | |
| Domain | UPA | 1.98e-04 | 5 | 84 | 2 | PF17217 | |
| Domain | Serpin_CS | 3.96e-04 | 32 | 84 | 3 | IPR023795 | |
| Domain | MFS_sugar_transport-like | 5.63e-04 | 36 | 84 | 3 | IPR005828 | |
| Domain | Serpin_dom | 5.63e-04 | 36 | 84 | 3 | IPR023796 | |
| Domain | Sugar_tr | 5.63e-04 | 36 | 84 | 3 | PF00083 | |
| Domain | SERPIN | 6.11e-04 | 37 | 84 | 3 | SM00093 | |
| Domain | SERPIN | 6.11e-04 | 37 | 84 | 3 | PS00284 | |
| Domain | Serpin | 6.61e-04 | 38 | 84 | 3 | PF00079 | |
| Domain | ZU5 | 7.05e-04 | 9 | 84 | 2 | SM00218 | |
| Domain | Ptc/Disp | 7.05e-04 | 9 | 84 | 2 | IPR003392 | |
| Domain | Patched | 7.05e-04 | 9 | 84 | 2 | PF02460 | |
| Domain | Serpin_fam | 7.14e-04 | 39 | 84 | 3 | IPR000215 | |
| Domain | Sugar_P_trans_dom | 8.79e-04 | 10 | 84 | 2 | IPR004853 | |
| Domain | DAGK_acc | 8.79e-04 | 10 | 84 | 2 | PF00609 | |
| Domain | Diacylglycerol_kin_accessory | 8.79e-04 | 10 | 84 | 2 | IPR000756 | |
| Domain | ZU5 | 8.79e-04 | 10 | 84 | 2 | PS51145 | |
| Domain | DAGKa | 8.79e-04 | 10 | 84 | 2 | SM00045 | |
| Domain | TPT | 8.79e-04 | 10 | 84 | 2 | PF03151 | |
| Domain | ZU5 | 1.28e-03 | 12 | 84 | 2 | PF00791 | |
| Domain | ZU5_dom | 1.28e-03 | 12 | 84 | 2 | IPR000906 | |
| Domain | SSD | 1.51e-03 | 13 | 84 | 2 | IPR000731 | |
| Domain | SSD | 1.51e-03 | 13 | 84 | 2 | PS50156 | |
| Domain | DAGKc | 1.76e-03 | 14 | 84 | 2 | SM00046 | |
| Domain | Diacylglycerol_kinase_cat_dom | 2.02e-03 | 15 | 84 | 2 | IPR001206 | |
| Domain | DAGK_cat | 2.02e-03 | 15 | 84 | 2 | PF00781 | |
| Domain | DAGK | 2.02e-03 | 15 | 84 | 2 | PS50146 | |
| Domain | NAD/diacylglycerol_kinase | 2.60e-03 | 17 | 84 | 2 | IPR016064 | |
| Domain | Aa_trans | 2.60e-03 | 17 | 84 | 2 | PF01490 | |
| Domain | AA_transpt_TM | 2.60e-03 | 17 | 84 | 2 | IPR013057 | |
| Domain | - | 2.92e-03 | 18 | 84 | 2 | 3.90.180.10 | |
| Domain | NA_NEUROTRAN_SYMP_2 | 2.92e-03 | 18 | 84 | 2 | PS00754 | |
| Domain | Fd_Rdtase_FAD-bd | 3.25e-03 | 19 | 84 | 2 | IPR017927 | |
| Domain | ADH_zinc_N | 3.25e-03 | 19 | 84 | 2 | PF00107 | |
| Domain | SNF | 3.25e-03 | 19 | 84 | 2 | PF00209 | |
| Domain | FAD_FR | 3.25e-03 | 19 | 84 | 2 | PS51384 | |
| Domain | NA_NEUROTRAN_SYMP_1 | 3.25e-03 | 19 | 84 | 2 | PS00610 | |
| Domain | NA_NEUROTRAN_SYMP_3 | 3.25e-03 | 19 | 84 | 2 | PS50267 | |
| Domain | ADH_SF_Zn-type | 3.25e-03 | 19 | 84 | 2 | IPR002085 | |
| Domain | ADH_C | 3.25e-03 | 19 | 84 | 2 | IPR013149 | |
| Domain | Na/ntran_symport | 3.25e-03 | 19 | 84 | 2 | IPR000175 | |
| Domain | Riboflavin_synthase-like_b-brl | 3.25e-03 | 19 | 84 | 2 | IPR017938 | |
| Domain | GroES-like | 5.17e-03 | 24 | 84 | 2 | IPR011032 | |
| Domain | EFh | 5.63e-03 | 158 | 84 | 4 | SM00054 | |
| Domain | DEATH | 6.52e-03 | 27 | 84 | 2 | SM00005 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC9A8 SLC36A1 SLCO4C1 SLC39A3 SLC22A16 SLC2A7 SLC34A2 SLC26A1 SLC6A14 | 2.25e-06 | 238 | 69 | 9 | MM15076 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC9A8 SLC36A1 SLCO4C1 SLC39A3 SLC22A16 SLC2A7 SLC34A2 SLC26A1 SLC6A14 | 3.26e-06 | 249 | 69 | 9 | M5988 |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 1.83e-04 | 108 | 69 | 5 | M823 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 1.91e-04 | 109 | 69 | 5 | MM15074 | |
| Pubmed | 2.46e-06 | 11 | 87 | 3 | 15203215 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 15203214 | ||
| Pubmed | Increased Th1 immune response in SERPINB3 transgenic mice during acute liver failure. | 6.19e-06 | 2 | 87 | 2 | 23354406 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 22406480 | ||
| Pubmed | Recurrent SERPINB3 and SERPINB4 mutations in patients who respond to anti-CTLA4 immunotherapy. | 6.19e-06 | 2 | 87 | 2 | 27668655 | |
| Pubmed | SLC35E2 promoter mutation as a prognostic marker of esophageal squamous cell carcinoma. | 6.19e-06 | 2 | 87 | 2 | 35247439 | |
| Pubmed | Characterization of novel squamous cell carcinoma antigen-related molecules in mice. | 6.19e-06 | 2 | 87 | 2 | 15504361 | |
| Pubmed | SCCA2-like serpins mediate genetic predisposition to skin tumors. | 6.19e-06 | 2 | 87 | 2 | 12702576 | |
| Pubmed | Serpinb3 is overexpressed in the liver in presence of iron overload. | 6.19e-06 | 2 | 87 | 2 | 28935635 | |
| Pubmed | Lysoptosis is an evolutionarily conserved cell death pathway moderated by intracellular serpins. | 6.19e-06 | 2 | 87 | 2 | 35022507 | |
| Pubmed | Overexpression of SERPIN B3 promotes epithelial proliferation and lung fibrosis in mice. | 6.19e-06 | 2 | 87 | 2 | 21403642 | |
| Pubmed | Structure-based mapping of DAF active site residues that accelerate the decay of C3 convertases. | 6.19e-06 | 2 | 87 | 2 | 17395591 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 25111616 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 11267667 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 29491058 | ||
| Pubmed | Squamous cell carcinoma antigen production in nasal inverted papilloma. | 6.19e-06 | 2 | 87 | 2 | 23168150 | |
| Pubmed | The serpin SQN-5 is a dual mechanistic-class inhibitor of serine and cysteine proteinases. | 6.19e-06 | 2 | 87 | 2 | 11863458 | |
| Pubmed | IgM-linked SerpinB3 and SerpinB4 in sera of patients with chronic liver disease. | 6.19e-06 | 2 | 87 | 2 | 22808225 | |
| Pubmed | Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma. | 6.19e-06 | 2 | 87 | 2 | 14970861 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 24891511 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 10653592 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 29112685 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 10956412 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 20428762 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 35874657 | ||
| Pubmed | 6.73e-06 | 15 | 87 | 3 | 30704515 | ||
| Pubmed | Serpin B3/B4, activated by STAT3, promote survival of squamous carcinoma cells. | 1.85e-05 | 3 | 87 | 2 | 19070595 | |
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 9828132 | ||
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 22451727 | ||
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 7724531 | ||
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 24898082 | ||
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 19074966 | ||
| Pubmed | A nonredundant role for mouse Serpinb3a in the induction of mucus production in asthma. | 1.85e-05 | 3 | 87 | 2 | 21126757 | |
| Pubmed | Diagnostic and prognostic role of SCCA-IgM serum levels in hepatocellular carcinoma (HCC). | 1.85e-05 | 3 | 87 | 2 | 24635038 | |
| Pubmed | Heparin enhances serpin inhibition of the cysteine protease cathepsin L. | 1.85e-05 | 3 | 87 | 2 | 19959474 | |
| Pubmed | Uteroglobin suppresses SCCA gene expression associated with allergic asthma. | 1.85e-05 | 3 | 87 | 2 | 15677460 | |
| Pubmed | Emerging role for autophagy in the removal of aggresomes in Schwann cells. | 3.70e-05 | 4 | 87 | 2 | 14627652 | |
| Pubmed | 3.70e-05 | 4 | 87 | 2 | 16549498 | ||
| Pubmed | Inhibitory mechanism of a cross-class serpin, the squamous cell carcinoma antigen 1. | 3.70e-05 | 4 | 87 | 2 | 12949073 | |
| Pubmed | 3.70e-05 | 4 | 87 | 2 | 21576355 | ||
| Pubmed | Biosynthesis of alkyl lysophosphatidic acid by diacylglycerol kinases. | 6.16e-05 | 5 | 87 | 2 | 22627129 | |
| Pubmed | 6.16e-05 | 5 | 87 | 2 | 15588329 | ||
| Pubmed | 6.16e-05 | 5 | 87 | 2 | 17015743 | ||
| Pubmed | 6.16e-05 | 5 | 87 | 2 | 17118363 | ||
| Pubmed | ASTE1 promotes shieldin-complex-mediated DNA repair by attenuating end resection. | 9.22e-05 | 6 | 87 | 2 | 34354233 | |
| Pubmed | 1.29e-04 | 7 | 87 | 2 | 23355739 | ||
| Pubmed | Cloning of three mouse Unc5 genes and their expression patterns at mid-gestation. | 1.29e-04 | 7 | 87 | 2 | 12351186 | |
| Pubmed | Peri-pubertal emergence of UNC-5 homologue expression by dopamine neurons in rodents. | 1.29e-04 | 7 | 87 | 2 | 20628609 | |
| Pubmed | RCE1 NCAPG EIF4ENIF1 P2RX4 RECQL4 MFSD6 HLA-G LAMP1 AK6 HSPA8 CYB5R1 | 1.59e-04 | 1168 | 87 | 11 | 19946888 | |
| Pubmed | 1.72e-04 | 8 | 87 | 2 | 14670299 | ||
| Pubmed | 1.72e-04 | 8 | 87 | 2 | 17010536 | ||
| Pubmed | Proteomic identification of exosomal LRG1: a potential urinary biomarker for detecting NSCLC. | 1.72e-04 | 8 | 87 | 2 | 21557262 | |
| Pubmed | 1.74e-04 | 43 | 87 | 3 | 24172014 | ||
| Pubmed | 2.12e-04 | 46 | 87 | 3 | 19190083 | ||
| Pubmed | Familial pure proximal renal tubular acidosis--a clinical and genetic study. | 2.20e-04 | 9 | 87 | 2 | 17881426 | |
| Pubmed | 2.20e-04 | 9 | 87 | 2 | 23457482 | ||
| Pubmed | 2.90e-04 | 126 | 87 | 4 | 16284245 | ||
| Pubmed | 3.06e-04 | 52 | 87 | 3 | 22632162 | ||
| Pubmed | Novel role for Netrins in regulating epithelial behavior during lung branching morphogenesis. | 3.35e-04 | 11 | 87 | 2 | 15186747 | |
| Pubmed | Analysis of Netrin 1 receptors during inner ear development. | 3.35e-04 | 11 | 87 | 2 | 17616930 | |
| Pubmed | 3.35e-04 | 11 | 87 | 2 | 33682352 | ||
| Pubmed | Combination of factor H mutation and properdin deficiency causes severe C3 glomerulonephritis. | 3.35e-04 | 11 | 87 | 2 | 23204401 | |
| Pubmed | 3.35e-04 | 11 | 87 | 2 | 17021016 | ||
| Pubmed | 3.35e-04 | 11 | 87 | 2 | 17698926 | ||
| Pubmed | 4.02e-04 | 12 | 87 | 2 | 18524992 | ||
| Pubmed | 4.02e-04 | 12 | 87 | 2 | 25456498 | ||
| Pubmed | 4.02e-04 | 12 | 87 | 2 | 20674402 | ||
| Pubmed | Genome-wide association analysis identifies three psoriasis susceptibility loci. | 4.74e-04 | 13 | 87 | 2 | 20953189 | |
| Pubmed | 4.74e-04 | 13 | 87 | 2 | 23427256 | ||
| Pubmed | 4.74e-04 | 13 | 87 | 2 | 25178676 | ||
| Pubmed | 4.74e-04 | 13 | 87 | 2 | 11863365 | ||
| Pubmed | 6.36e-04 | 15 | 87 | 2 | 23506890 | ||
| Pubmed | Muscle contraction is necessary to maintain joint progenitor cell fate. | 6.36e-04 | 15 | 87 | 2 | 19460349 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 7.22e-04 | 774 | 87 | 8 | 15302935 | |
| Pubmed | Programme of self-reactive innate-like T cell-mediated cancer immunity. | 7.26e-04 | 16 | 87 | 2 | 35444279 | |
| Pubmed | Tissue distribution, ontogeny, and hormonal regulation of xenobiotic transporters in mouse kidneys. | 7.26e-04 | 16 | 87 | 2 | 19679677 | |
| Pubmed | Activated Hedgehog-GLI Signaling Causes Congenital Ureteropelvic Junction Obstruction. | 7.26e-04 | 16 | 87 | 2 | 29109083 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | RCE1 TPST1 PTPRS HYAL3 CD55 LAMP1 FUCA2 SLC43A3 ZZEF1 AMIGO2 | 8.36e-04 | 1201 | 87 | 10 | 35696571 |
| Pubmed | 1.38e-03 | 22 | 87 | 2 | 27407143 | ||
| Pubmed | 1.38e-03 | 22 | 87 | 2 | 22726835 | ||
| Pubmed | Recombination in the class III region of the mouse major histocompatibility complex. | 1.38e-03 | 22 | 87 | 2 | 7916002 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | 1.43e-03 | 1070 | 87 | 9 | 23533145 | |
| Pubmed | A genomic analysis of rat proteases and protease inhibitors. | 1.51e-03 | 23 | 87 | 2 | 15060002 | |
| Pubmed | Synergistic integration of Netrin and ephrin axon guidance signals by spinal motor neurons. | 1.65e-03 | 24 | 87 | 2 | 26633881 | |
| Pubmed | NDP52 interacts with mitochondrial RNA poly(A) polymerase to promote mitophagy. | 1.79e-03 | 25 | 87 | 2 | 30309841 | |
| Pubmed | Ubiquitin ligase MARCH5 localizes to peroxisomes to regulate pexophagy. | 1.79e-03 | 25 | 87 | 2 | 34747980 | |
| Pubmed | 1.79e-03 | 25 | 87 | 2 | 24947832 | ||
| Pubmed | 1.93e-03 | 26 | 87 | 2 | 20205591 | ||
| Pubmed | 2.01e-03 | 212 | 87 | 4 | 19521566 | ||
| Pubmed | Control of TurboID-dependent biotinylation intensity in proximity ligation screens. | 2.05e-03 | 100 | 87 | 3 | 36966971 | |
| Pubmed | 2.17e-03 | 102 | 87 | 3 | 10231032 | ||
| Pubmed | 2.19e-03 | 217 | 87 | 4 | 34048709 | ||
| Pubmed | 2.24e-03 | 28 | 87 | 2 | 38324473 | ||
| Pubmed | 2.40e-03 | 29 | 87 | 2 | 28049658 | ||
| Pubmed | 2.50e-03 | 225 | 87 | 4 | 31478661 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 2.50e-03 | 736 | 87 | 7 | 29676528 | |
| Cytoband | 18q21.3 | 1.93e-04 | 11 | 87 | 2 | 18q21.3 | |
| GeneFamily | Solute carriers | SLC9A8 SLC38A10 SLC36A1 SLCO4C1 SLC39A3 SLC22A16 SLC6A16 SLC2A7 SLC35E2A SLC34A2 SLC43A3 SLC35E2B SLC26A1 SLC6A14 SLC22A31 | 2.68e-12 | 395 | 61 | 15 | 752 |
| GeneFamily | Serpin peptidase inhibitors | 2.62e-04 | 37 | 61 | 3 | 739 | |
| GeneFamily | EF-hand domain containing|Diacylglycerol kinases | 4.95e-04 | 10 | 61 | 2 | 1178 | |
| Coexpression | GSE37301_LYMPHOID_PRIMED_MPP_VS_CD4_TCELL_UP | 3.54e-06 | 196 | 85 | 7 | M8858 | |
| ToppCell | (05)_Secretory|World / shred by cell type by condition | 4.89e-09 | 196 | 87 | 8 | 8032c25b51ef96aeba28cc52686a2bd45213453d | |
| ToppCell | BL-critical-LOC-Epithelial-Secretory|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.42e-08 | 190 | 87 | 7 | f2abe4bc28e934287e2dcd7b9399d5af78c5c8cf | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.76e-08 | 191 | 87 | 7 | 529068029fb461df766135576dd0d8b5980f9bc0 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Secretory|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.21e-07 | 197 | 87 | 7 | a72047b7428c0d4aaf016c1ac23dc30919260fd8 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.29e-07 | 199 | 87 | 7 | 8bf8d7cd774479f065bbbbcb5a4bd1aa91aa0d85 | |
| ToppCell | distal-2-Epithelial-Mucous|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.29e-07 | 199 | 87 | 7 | c0275b5011c2bb08e873955afe2e213ec8070d0e | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.29e-07 | 199 | 87 | 7 | 0c060ef64341659f4b1247d0264ac12e53a7e12e | |
| ToppCell | control-Epithelial-Secretory|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.29e-07 | 199 | 87 | 7 | 262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-Goblet-Goblet|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.08e-06 | 171 | 87 | 6 | 25c1979e972c959e1ce4c57804f976f53a247ad7 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-Goblet|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.08e-06 | 171 | 87 | 6 | fe27bf581c75ef33c2848878e51ed16b275a4c8e | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.16e-06 | 173 | 87 | 6 | d1e47c87bd4750801f3531f66a56c5dccb4ea64c | |
| ToppCell | 18-Airway-Epithelial-Club-like_secretory|Airway / Age, Tissue, Lineage and Cell class | 1.82e-06 | 187 | 87 | 6 | d1e301afcc39054ae1f867d80e564e30a137e3f8 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.99e-06 | 190 | 87 | 6 | 6ea9fa08bd97bedcb21d3654467e7f8dd74c8fd0 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.99e-06 | 190 | 87 | 6 | 23f2ac4da431211084bb6ab0494c2e0b69547cb6 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.99e-06 | 190 | 87 | 6 | 3c337374d89e69cc0a78e65a4a7e21db7b050fcd | |
| ToppCell | NS-critical-d_07-13-Epithelial-Secretory|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.25e-06 | 194 | 87 | 6 | 2172d951896265243d14996eacce5aab5e14e26e | |
| ToppCell | Nasal_Brush|World / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.31e-06 | 195 | 87 | 6 | 7509b980b6b293df02bec619ef5b83a6c7b49c03 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.31e-06 | 195 | 87 | 6 | 3f8ed20ad17afe1545e574e5ca5fe33c3704c7f3 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.38e-06 | 196 | 87 | 6 | 2c3fbfbb08cd327cd97b3fa5a6f83b6d50771fb7 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.38e-06 | 196 | 87 | 6 | a52879a4c822c5e4be569f01f845a795e00c5f4b | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.38e-06 | 196 | 87 | 6 | 7a4d502550e9e37dc42f2ff1be3c896afe365d7f | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Secretory|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.38e-06 | 196 | 87 | 6 | 47930de6b47b7bf22d8dae8b7419a9cd1d22f0ea | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.38e-06 | 196 | 87 | 6 | 60ea673ed887fe3890c5cf4ff4165384b76d7361 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.46e-06 | 197 | 87 | 6 | adb4e27d73ae2e6a39d212c0ead3ac0ad62d9131 | |
| ToppCell | proximal-3-Epithelial-Goblet|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.53e-06 | 198 | 87 | 6 | 3477202c4f702d8f75231b13d4b5216f56d981d7 | |
| ToppCell | proximal-Epithelial-Goblet|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.53e-06 | 198 | 87 | 6 | e7e1c430486a81280abc4a7e7f5bc3713dd20737 | |
| ToppCell | BL-critical-LOC-Epithelial-Secretory_LYPD2|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.53e-06 | 198 | 87 | 6 | 484d16aaa601a1e11b871b0475dd01a2de1a29ce | |
| ToppCell | proximal-Epithelial-Goblet-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.53e-06 | 198 | 87 | 6 | da7b40eb00bb5e454e1cfcd1219dc0d84712592a | |
| ToppCell | medial-2-Epithelial-Mucous|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.60e-06 | 199 | 87 | 6 | 4737250b7ffa7cc19eb6b057d35d78f13b1afe66 | |
| ToppCell | medial-Epithelial-Mucous|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.60e-06 | 199 | 87 | 6 | 4385963ab25b5378e7964b984028c25b27e5794e | |
| ToppCell | NS-control-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.60e-06 | 199 | 87 | 6 | 32bdfff40fd442b88489c8b0f79af3927a51a03c | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.60e-06 | 199 | 87 | 6 | 3c3133d0aa65338a576634def13e7f0f5c573a10 | |
| ToppCell | (04)_Interm._basal>secr.|World / shred by cell type by condition | 2.60e-06 | 199 | 87 | 6 | ed399244433f781fc291a9bff16825b8a3ca294f | |
| ToppCell | control-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.60e-06 | 199 | 87 | 6 | 3d01f90ffd271ca00129192787e4921bdca7e01e | |
| ToppCell | Biopsy_IPF-Epithelial-MUC5AC+_High|Biopsy_IPF / Sample group, Lineage and Cell type | 2.60e-06 | 199 | 87 | 6 | 51cb306e36537a53968c55187bd87c83e1706187 | |
| ToppCell | distal-Epithelial-Mucous-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.60e-06 | 199 | 87 | 6 | 0af89ef40807fc4ad79ab82a2186ab6e866c6931 | |
| ToppCell | medial-Epithelial-Mucous-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.60e-06 | 199 | 87 | 6 | 53198bcf5f2f012a3ed1600d95c0923d6976a099 | |
| ToppCell | distal-Epithelial-Mucous|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.60e-06 | 199 | 87 | 6 | a7fe7b792d696f369ad0310a772160a1729ef223 | |
| ToppCell | moderate-Epithelial-Secretory-diff|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.68e-06 | 200 | 87 | 6 | 6f29ef9dcf126c5c19386f6aa9a20c38a2c8ccc8 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_basal-Suprabasal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.68e-06 | 200 | 87 | 6 | 5f0f67958c9635db53e61f8370a92da6ea3e80fe | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Secretory-diff|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.68e-06 | 200 | 87 | 6 | 8f179b5768fd504af6dd6f6749a0bed7b689e77f | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Club|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 2.68e-06 | 200 | 87 | 6 | 85f946dd3831acf3488c87efba96689cc2667c3a | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_secretory|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.68e-06 | 200 | 87 | 6 | 8f811ddd84c037a250d124496b0fbb2e4717011c | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Club-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.68e-06 | 200 | 87 | 6 | 8a44a4f7ea9358f2194a490e79601c98ff7fdcb0 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Club|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.68e-06 | 200 | 87 | 6 | 30d428510c68da96c7c8cfd472f449ebb9631132 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Ductal_and_Metaplastic_Carcinoma-4|TCGA-Breast / Sample_Type by Project: Shred V9 | 4.35e-06 | 123 | 87 | 5 | 11802979943a9205f10facda322fc220d4bf7133 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Ductal_and_Metaplastic_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9 | 4.35e-06 | 123 | 87 | 5 | 51e49a64fbbf77e2ee21f45fd515d43282b11516 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-IRC-IFNG_responsive_cell|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.10e-06 | 136 | 87 | 5 | 7f1ca43e0d164b511120316d4218d80ba21a9b5c | |
| ToppCell | Club_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.11e-05 | 149 | 87 | 5 | 81c813588bb5efb7b31141a75d387210dcb76094 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.51e-05 | 159 | 87 | 5 | 60b1f4dce2ce0911160fda17f137c064da31e2eb | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.66e-05 | 162 | 87 | 5 | c7114e24cb5525abb9780ca3d35dbcc4eabd4b64 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.66e-05 | 162 | 87 | 5 | f1851a173d3bcca2981d934161ec85d1cc0af5a2 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.66e-05 | 162 | 87 | 5 | 5d902bb31e691aea9749617cc88303c2448f24b8 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Calb2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.75e-05 | 79 | 87 | 4 | 03c5af851b53800eced1c74e9da374c71092bcd4 | |
| ToppCell | NS-critical-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.03e-05 | 169 | 87 | 5 | aec97583b23112060437b619cb429dc32f29285f | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.4|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.27e-05 | 173 | 87 | 5 | 176b956e71d98e8275d698b39437fc326e5fe449 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.34e-05 | 174 | 87 | 5 | 207aa0118633cbe9a65839bbb1bb3ba9f8118ad2 | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-05 | 181 | 87 | 5 | 97022416d0f5a5ba9c9bd5e70ce95cf4cb19af89 | |
| ToppCell | Control-Myeloid-DC1|Control / Condition, Lineage and Cell class | 2.82e-05 | 181 | 87 | 5 | 5a2a1f017ad23baed9972c68b4a46f4c618ef21a | |
| ToppCell | facs-Large_Intestine-Distal-24m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-05 | 182 | 87 | 5 | 398ce074a04f6482470b488f1affae4af7d2ec58 | |
| ToppCell | PSB-critical-LOC-Epithelial-Secretory_LYPD2|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.07e-05 | 91 | 87 | 4 | 9c61b9f3e9e4f0c9cb242e313d642c2b75705c88 | |
| ToppCell | COPD-Epithelial-Goblet|World / Disease state, Lineage and Cell class | 3.21e-05 | 186 | 87 | 5 | d75fe7640a4b2c450c9759a1b3c3ef2a087f0092 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Pulmonary_neuroendocrine|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.21e-05 | 186 | 87 | 5 | fcabebdfbf1b1dbb35ce2b3c53a60d2b1aed8e6c | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.30e-05 | 187 | 87 | 5 | f5a202d5f8eb57b57d80815ce98774e04c387383 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.47e-05 | 189 | 87 | 5 | b06471b1bebb990d5146bddfb8002401c6b099a0 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.47e-05 | 189 | 87 | 5 | a8246acf31f02c85421268245afb651aa8788f14 | |
| ToppCell | IPF-Epithelial-Goblet|IPF / Disease state, Lineage and Cell class | 3.56e-05 | 190 | 87 | 5 | e41dd5a997ad9952810ffecb57737c03ea1d88b3 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.74e-05 | 192 | 87 | 5 | 29f49f00770c991b5f27e4cb701dd2d2d6cb7178 | |
| ToppCell | COPD-Epithelial-Goblet|COPD / Disease state, Lineage and Cell class | 3.74e-05 | 192 | 87 | 5 | 93b2ca0a97776d28c7e8f1a0642c4b63a5554aab | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.83e-05 | 193 | 87 | 5 | 463274f394757fb2570ae885d58e1f9fa7e60c4a | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 3.83e-05 | 193 | 87 | 5 | ca7c0a4ceb05bced90f6cdc53d278e547fb241e9 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.83e-05 | 193 | 87 | 5 | 8ede7038a222c7e7ecaf7e86520823cf606cbee7 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.83e-05 | 193 | 87 | 5 | 0e7d7adfaa7191e34038fcda6677561ae13934eb | |
| ToppCell | distal-Epithelial-Differentiating_Basal-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.02e-05 | 195 | 87 | 5 | 3fe6e49a9161fc9e5160251e6932cb5378175a54 | |
| ToppCell | NS-critical-LOC-Epithelial-Secretory|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.02e-05 | 195 | 87 | 5 | b0d782eeee30c797b4da9b3be29b864983fd9e71 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.02e-05 | 195 | 87 | 5 | 6095bb237d7bc75cbaeaeb492f6948f3c3fa4848 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.12e-05 | 196 | 87 | 5 | c18874f37b90e6afacc562b2082b67ea8a7cb4a4 | |
| ToppCell | COVID-19-Epithelial-Club,_Basal_cells|COVID-19 / Condition, Lineage and Cell class | 4.12e-05 | 196 | 87 | 5 | dd32046067d93b9484cfbf1d7826a436a3d9f0e9 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.12e-05 | 196 | 87 | 5 | 5789b5b0763d6eab21bf4da1fd8eae6116f46f3f | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_secretory-Secretory_Club|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.12e-05 | 196 | 87 | 5 | d5f9168001e60bafec17fe6c702e68f5528edc20 | |
| ToppCell | critical-Epithelial-Secretory|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.12e-05 | 196 | 87 | 5 | 7da687eb983a54c28ee990424cc52e01caf5f4aa | |
| ToppCell | critical-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.12e-05 | 196 | 87 | 5 | dbf14f5851c2b779a8b35e820c4584ea9096e49d | |
| ToppCell | distal-3-Epithelial-Proximal_Basal|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.12e-05 | 196 | 87 | 5 | 7e1a565dd2da4f375cbce8842ba4fd6c22ac8375 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.12e-05 | 196 | 87 | 5 | 8e96fc87812d112ccae6e2ca1821bee1ee2efe48 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Club|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.12e-05 | 196 | 87 | 5 | 057d150bdf0cad959fd03ec2d1560a96ba03fae9 | |
| ToppCell | distal-3-Epithelial-Goblet|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.22e-05 | 197 | 87 | 5 | a00784ccfb1de6a96b91e2a8a2889b69f31a33da | |
| ToppCell | Bronchial_Biopsy-Epithelial-Club|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.22e-05 | 197 | 87 | 5 | 3f5dfa892a1f631b96eeb6f4cfc284aee51d1ce6 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_basal-Dividing_Basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.22e-05 | 197 | 87 | 5 | 25bbe270d0897b9b1bd00d205f66efd1def81b99 | |
| ToppCell | Bronchus_Control_(B.)|World / Sample group, Lineage and Cell type | 4.22e-05 | 197 | 87 | 5 | b6dff2ee108813e18657e2d8cf850e2423f8c8e9 | |
| ToppCell | Biopsy_Other_PF-Epithelial-MUC5AC+_High|Biopsy_Other_PF / Sample group, Lineage and Cell type | 4.33e-05 | 198 | 87 | 5 | 30e6177e216f66caddcd009fafef0e07369f4d8e | |
| ToppCell | moderate-Epithelial-Secretory|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.33e-05 | 198 | 87 | 5 | 7d96d7105a849c7280ce87bd76ce130ac47384fd | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.33e-05 | 198 | 87 | 5 | 3cc9e671f596ef0829684018e4257571fefb6267 | |
| ToppCell | moderate-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.33e-05 | 198 | 87 | 5 | 7ecce5e266bb08797088cc8f8309e0c7b48df5c9 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.33e-05 | 198 | 87 | 5 | 5dd2aa7684c36beffa204ca4c04d0501cabac10f | |
| ToppCell | NS-critical-LOC-Epithelial-Secretory_LYPD2|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.33e-05 | 198 | 87 | 5 | 4a481e1edb80b950c823ed926842cd5132cfb27f | |
| ToppCell | NS-critical-d_0-4-Epithelial-IRC-IFNG_responsive_cell|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.33e-05 | 198 | 87 | 5 | cf612c09a782b6ddc17e723865b8c0c7ddb19761 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Secretory-diff|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.33e-05 | 198 | 87 | 5 | 361f3062f73a0add16dd6fbe927698416515879f | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.33e-05 | 198 | 87 | 5 | f088badb90c6c2d916195f5649eda102119c9ac6 | |
| ToppCell | proximal-Epithelial-Differentiating_Basal-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.43e-05 | 199 | 87 | 5 | c607346f60e5997e757e5a31cab412ab3734377b | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Erythro-Megakary|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.43e-05 | 199 | 87 | 5 | f894c88ecc7fd0edca28587801fa59352d10f750 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 9.51e-05 | 50 | 52 | 4 | GAVISH_3CA_MALIGNANT_METAPROGRAM_30_PDAC_CLASSICAL | |
| Drug | sodium | CACNA1S SLC9A8 SLC36A1 P2RX4 SLC22A16 SLC6A16 CLN3 SLC2A7 SLC34A2 DUOX2 GCDH SLC43A3 SLC26A1 CFB SLC6A14 | 1.96e-06 | 944 | 85 | 15 | CID000000923 |
| Disease | insulin metabolic clearance rate measurement, glucose homeostasis measurement | 7.92e-06 | 14 | 84 | 3 | EFO_0006830, EFO_0006896 | |
| Disease | neutrophil measurement | 1.66e-03 | 177 | 84 | 4 | EFO_0803548 | |
| Disease | glucose metabolism disease (implicated_via_orthology) | 2.88e-03 | 28 | 84 | 2 | DOID:4194 (implicated_via_orthology) | |
| Disease | eosinophil measurement | 3.66e-03 | 108 | 84 | 3 | EFO_0803540 | |
| Disease | Complement deficiency disease | 3.99e-03 | 33 | 84 | 2 | C0272242 | |
| Disease | refractive error, self reported educational attainment | 4.23e-03 | 34 | 84 | 2 | EFO_0004784, MONDO_0004892 | |
| Disease | cervical cancer (is_marker_for) | 4.74e-03 | 36 | 84 | 2 | DOID:4362 (is_marker_for) | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 4.74e-03 | 36 | 84 | 2 | DOID:11723 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LIFIGGVPRSGTTLM | 71 | O60507 | |
| LPLILVAMGLVIAGG | 256 | A8MVZ5 | |
| LIPLMVGLGLSASTV | 391 | Q9N2K0 | |
| LIPLMVGLGLSASTI | 391 | Q9N2J8 | |
| VISGVMSLLGLALAP | 86 | Q9BWW8 | |
| LLMITVTVGPGASGV | 26 | Q86SJ2 | |
| VLVGLGSEMTTVPLL | 271 | Q00796 | |
| LAGITGILMSAAGLP | 331 | Q9Y2E6 | |
| AISLPTIGGSQALML | 106 | Q9UKI2 | |
| TMLVGPLIAIINSPG | 491 | Q2TB18 | |
| DIIPTMINIGSGLAL | 331 | Q99571 | |
| MLLPNILLTGTPGVG | 1 | Q9Y3D8 | |
| LMPFILGLLSGGVTT | 11 | P00751 | |
| SSLPTIPIMGIVAGL | 301 | P17693 | |
| GGNLLILVAVASMPS | 41 | Q8NH08 | |
| IQPLSTGTMTGLAIQ | 111 | P21941 | |
| TGVPKTGLLMTVLGI | 196 | Q96LZ2 | |
| GLGRNIILTTMPAGT | 1216 | Q6P4R8 | |
| VSMFPLGGLLGSLLV | 81 | Q6PXP3 | |
| MGLLLTVDPGSGTVL | 206 | Q76MJ5 | |
| TLTGLLGTLVTMGLL | 366 | P08174 | |
| TVPGMTGVLLLLVLA | 1186 | Q9NRD8 | |
| ELTGIQPGTSLLTLM | 91 | Q9Y256 | |
| IMESGVALLPGLIAS | 251 | O00748 | |
| RAGLGSIIPLQLLTM | 3841 | Q9Y4D8 | |
| LGMSPSQSGLLVGIR | 96 | Q6ZSS7 | |
| SVVGPMGLLVVLLVG | 11 | Q13332 | |
| AGVAMTNLPGILVLG | 1241 | Q9UHC9 | |
| TGFIMLRNGLLTIPV | 151 | Q8NH76 | |
| VHGGMTTIPLLVLLG | 246 | P49619 | |
| GNLLMNIGPTLDGTI | 331 | Q9BTY2 | |
| IPLMQGNLPTLTLSG | 21 | P30968 | |
| IISEMGELGVLGPTI | 96 | Q92947 | |
| ILLVESGAMTPLGIS | 511 | Q13698 | |
| NIISLMSAGILGVPP | 101 | Q06889 | |
| MVGQLGILTPSLTLP | 226 | Q8N6W0 | |
| MTTQLGPALVLGVAL | 1 | O43820 | |
| GILLPFMLLSQGLGV | 211 | Q6NUI2 | |
| QGGMTTIPLLVLLGL | 221 | Q9Y6T7 | |
| IMSINGTSLVGLPLS | 706 | Q02410 | |
| SMLIPIAVGGALAGL | 381 | P11279 | |
| GIPTVGMAVGILLTT | 781 | Q12864 | |
| GMAVGILLTTLLVIG | 786 | Q12864 | |
| PVLLLGTMVTGLASL | 396 | A6NKX4 | |
| LSVVFGTMVGGILIP | 326 | Q9HBR0 | |
| GTMVGGILIPNVETI | 331 | Q9HBR0 | |
| VTPLSLGIETAGGVM | 396 | P11142 | |
| SSAIGIMQGIITPLQ | 511 | Q9GZN6 | |
| TPLMVNGILGESVTL | 26 | Q96DU3 | |
| LMTVSNLGVIFGPTL | 526 | A6NI28 | |
| GLMVITGSESPIVLL | 26 | P0C7V7 | |
| SNLGGMATIPSIQLL | 416 | Q5UIP0 | |
| VLMLTPEALVGAGGL | 576 | O94761 | |
| ILLMGIVGPITAGIL | 86 | Q8WVE7 | |
| GTMALLSGVLTLKLP | 511 | Q86VW1 | |
| LPGMGTTIDVILING | 866 | O60841 | |
| PVTDGAISTLLGLLM | 1061 | Q9Y6C5 | |
| ILSLLGGEPSMLGAV | 96 | P0CK97 | |
| VSAMIPLGIGLGLGI | 236 | Q9BRY0 | |
| VLFTILLLGGSTMPL | 456 | Q9Y2E8 | |
| PMLTIGGILFLITNL | 131 | Q8NBI5 | |
| MGIQTSPVLLASLGV | 1 | Q9UHQ9 | |
| NTMGPIGVTLALLPL | 136 | Q92781 | |
| PISITSALGMVLLGA | 31 | P29508 | |
| GTSLGMVLIISLNLP | 856 | Q9Y2K9 | |
| GLMGSLEPTTSLLGQ | 546 | Q9NRA8 | |
| GTAIQVAGIGVLPML | 176 | H7C241 | |
| GLSPQQTLLSMLGIP | 206 | Q13286 | |
| MNGIIESLILPGIIS | 581 | Q9BPX3 | |
| NSSIMSNPLLGLVIG | 136 | O95436 | |
| GPVLLIAGATVLMEG | 6 | Q2L4Q9 | |
| LSGTIPVQMLLEIGL | 411 | Q9H900 | |
| LMTIGQSLLQGTLQP | 206 | Q05516 | |
| TLGGIGLVTVGIMSI | 201 | A6NGC4 | |
| GIVMGPISLLIIGIV | 76 | Q7Z2H8 | |
| GDVMSGLVIGIILVP | 71 | Q9H2B4 | |
| PVGILTAIGMVLLGT | 31 | Q9UIV8 | |
| GIQFMVLRLLGTIPG | 616 | Q6ZQN7 | |
| VLGATEPLTSGQLLM | 416 | Q8TB22 | |
| GGMIVITSILGSLPF | 206 | O75631 | |
| PISITSALGMVLLGA | 31 | P48594 | |
| ILSLLGGEPSMLGAV | 96 | P0CK96 | |
| GLLVNLSLIPVMGGL | 196 | P0CK96 | |
| STPILKMLLIQGGTL | 2211 | Q86WI1 | |
| LGGRLVMPNTGVSLL | 551 | Q6UXZ4 | |
| QGTPTTGLLMIVLGL | 171 | Q96MG7 | |
| GGRLMIPNTGISLLI | 451 | Q6ZN44 | |
| LLMLSGAPGEVGSVL | 946 | O43149 | |
| LPLFQGVGITMVLIS | 111 | Q9UN76 | |
| GAIGMPGLTSLIGIQ | 131 | Q8N8N7 | |
| GILGSGVLMIFPALV | 51 | P48230 | |
| NGLLIGTTGVMLQSP | 286 | O14544 | |
| PQVMLISLLAGGVGL | 1061 | Q9UNY4 |